Increased secretion of pro-inflammatory cytokines by circulating polymorphonuclear neutrophils and regulation by interleukin 10 during intestinal inflammation
about
Neutrophil derived human S100A12 (EN-RAGE) is strongly expressed during chronic active inflammatory bowel diseaseGenetic update on inflammatory factors in ulcerative colitis: Review of the current literatureProbiotics in the management of atopic eczemaOsteopontin and mucosal protectionLPS-Stimulated Whole Blood Cytokine Production Is Not Related to Disease Behavior in Patients with Quiescent Crohn's DiseaseIL-1beta and IL-10 have dual effects on enteric glial cell proliferation.Long-term follow-up with Granulocyte and Monocyte Apheresis re-treatment in patients with chronically active inflammatory bowel disease.Serum calprotectin levels correlate with biochemical and histological markers of disease activity in TNBS colitisCytapheresis in patients with severe ulcerative colitis after failure of intravenous corticosteroid: a long-term retrospective cohort study.Effects of adacolumn selective leukocytapheresis on plasma cytokines during active disease in patients with active ulcerative colitis.Treating inflammatory bowel disease by adsorptive leucocytapheresis: a desire to treat without drugs.Complex role for the immune system in initiation and progression of pancreatic cancer.Dynamics of a cytokine storm.Induction of CD36 and thrombospondin-1 in macrophages by hypoxia-inducible factor 1 and its relevance in the inflammatory processEfficacy, safety and cost analyses in ulcerative colitis patients undergoing granulocyte and monocyte adsorption or receiving prednisolone.Colonic inflammation in mice is improved by cigarette smoke through iNKT cells recruitment.Cytapheresis as a Non-Pharmacological Therapy for Inflammatory Bowel Disease.Treatment of children and adolescents with ulcerative colitis by adsorptive depletion of myeloid lineage leucocytes as monotherapy or in combination with low dose prednisolone after failure of first-line medications.Decrease of reactive-oxygen-producing granulocytes and release of IL-10 into the peripheral blood following leukocytapheresis in patients with active ulcerative colitis.Deficiency of Nuclear Receptor Nur77 Aggravates Mouse Experimental Colitis by Increased NFκB Activity in Macrophages.Neuronal guidance molecule netrin-1 attenuates inflammatory cell trafficking during acute experimental colitisEnhanced production of early lineages of monocytic and granulocytic cells in mice with colitisDevelopments in the apheresis procedure for the treatment of inflammatory bowel disease.Relationship between genotype and phenotype of flagellin C in Salmonella.The logics of leukocytapheresis as a natural biological therapy for inflammatory bowel disease.Clinical value of fecal calprotectin in determining disease activity of ulcerative colitisGranulocytapheresis in the treatment of patients with active ulcerative colitis.The mode of actions of the Adacolumn therapeutic leucocytapheresis in patients with inflammatory bowel disease: a concise review.Cells, cytokines and inflammatory bowel disease: a clinical perspective.Current status and future perspectives of leukocytapheresis for inflammatory bowel disease.Autophagy mediates neutrophil responses to bacterial infection.Toward a better understanding of the central consequences of intestinal inflammation.Protective role of Akt2 in Salmonella enterica serovar typhimurium-induced gastroenterocolitis.Anti-inflammatory properties of dairy lactobacilli.Neutrophil volume distribution width as a new marker in detecting inflammatory bowel disease activation.Tumor necrosis factor regulates intestinal epithelial cell migration by receptor-dependent mechanisms.Trichostrongylus colubriformis extract upregulates TNF-alpha receptor expression and enhances TNF-alpha sensitivity of L929 cells.TNF-alpha potentiates the ion secretion induced by muscarinic receptor activation in HT29cl.19A cells.Apoptosis of human gastric epithelial cells via caspase-3 activation in response to Helicobacter pylori infection: possible involvement of neutrophils through tumor necrosis factor alpha and soluble Fas ligands.The influence of cigarette smoking on cytokine levels in patients with inflammatory bowel disease.
P2860
Q24669692-94DEC905-18C3-4667-951D-F0644615770FQ26852514-BC07D04B-5345-4780-A6FD-D6BF1C9EDA53Q28143271-5D0E1A95-A345-420A-B8CF-C0160AE03419Q28236080-E59242BA-3585-448F-A09B-56A77C35F975Q28546744-0EF3BCE0-444C-4CEF-B718-6620601B43B0Q31907584-82F70609-64F9-4FB6-AA84-12C97AD3EBBDQ33626027-6433C712-C497-4D30-A7F8-679F35DD4AADQ33840425-BFADC83A-AE59-4BE8-9ED8-51823BA0A13AQ33855532-78BED08E-501A-4345-B4AB-34D812782DBFQ33867970-9F2E4E2B-42F0-4D6D-9928-B64D1AFA5295Q34008773-C6F3871C-2975-4D67-81C1-F75B89EFDB3BQ34093784-960A3CE7-41F4-406F-9E05-4648ECD4D6BBQ34437535-B54133BA-3013-43D1-A190-1C92D4340A29Q34465254-1B3EED8A-819F-4930-A38E-1BD7A2DD005EQ34604561-34D99E9A-78CE-4530-BACB-DCCC7ABBFB3BQ34701073-E02E7246-BC53-492D-B651-A8558583BA4AQ34870365-85FA06FD-457C-4A0B-BB77-FC4F7F61CE44Q34958550-F54A39EF-F896-4F79-8481-C71A64D61D55Q35010974-F09C339E-6FEB-4C6D-A117-25E37F5628BAQ35737476-A9705375-B1BA-4D96-BF6F-1125708F654AQ35878812-852BA896-8C44-46EC-9187-DDE85DD5BDF5Q36339826-7F61C130-4E73-4AC1-BE9B-0F439391198FQ36353616-873B6194-DBFF-487F-BA35-ADDDECF1F0F8Q36415730-3910E50D-916B-44F5-9526-BA7A863904B3Q36446929-0821F528-42F3-4319-93AA-13515E2F7FC3Q37169713-5747CC57-9967-4AA2-8987-877F97A0AB45Q37345830-B215F1F9-987B-44C4-AAD3-917F1564F6E4Q37809574-3A7CC259-D51B-40D1-82AF-6F9B6AD0C423Q37948155-E7FAFA3D-2A82-468C-BC8E-D7535D5895BAQ37993226-2BA937A5-5874-4CCE-8333-660524694A2CQ38204787-7F8E54DB-0880-4BA4-810F-DED0946AD026Q38588312-09955B91-19BE-4BEE-B2A6-C11376940228Q38687010-8D0991EF-DC70-4BC4-8861-011BA2C6CED0Q39491174-8A7F98C8-CB08-4AF3-B560-EF364151099AQ40467985-3916DD2A-9F2A-484E-BA48-48BEFC2B0BF8Q40685684-73113436-66C1-40A5-BBC0-F5C66B7A8F26Q40837763-7109ACFD-A9A5-4B55-A2CA-C87B159BA90DQ40894653-B64EE497-C78A-48DF-8B24-16876A670479Q40900352-BAE9F8EC-21CF-41BA-9D06-0E11B5713EA2Q41666854-3561E856-C878-4B48-9AE9-248511062A44
P2860
Increased secretion of pro-inflammatory cytokines by circulating polymorphonuclear neutrophils and regulation by interleukin 10 during intestinal inflammation
description
1998 nî lūn-bûn
@nan
1998 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
Increased secretion of pro-inf ...... during intestinal inflammation
@ast
Increased secretion of pro-inf ...... during intestinal inflammation
@en
type
label
Increased secretion of pro-inf ...... during intestinal inflammation
@ast
Increased secretion of pro-inf ...... during intestinal inflammation
@en
prefLabel
Increased secretion of pro-inf ...... during intestinal inflammation
@ast
Increased secretion of pro-inf ...... during intestinal inflammation
@en
P2093
P2860
P356
P1433
P1476
Increased secretion of pro-inf ...... during intestinal inflammation
@en
P2093
P2860
P304
P356
10.1136/GUT.42.4.470
P407
P577
1998-04-01T00:00:00Z